Remember that reference ranges vary between laboratories, and results should be interpreted in clinical context
doi: 10.3389/fphar.2025.1737199 Received 01 November 2025 Revised 21 December 2025 Accepted 29 December 2025 Published 15 January 2026 Volume 16 - 2025 Edited by Dawei Chen, University of Kiel, Germany Reviewed by Eveljn Scarian, University of Pavia, Italy Hong Cheng, Yangzhou University, China Updates Copyright 2026 Knudsen, Tadje, Coggins and Venketaraman
According to obesity treatment guidelines, patients should demonstrate approximately 5% weight loss after 12 weeks at the maintenance dose to continue therapy
A mjsejtekben zajl intenzv szintzis biztostja, hogy folyamatosan rendelkezsre lljon a toxikus anyagok feldolgozshoz s a kros oxidatv hatsok semlegestshez
Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections